Same-day discharge after complex gynecologic oncology surgery is safe and feasible, with success tied to age, BMI, surgery ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

Julian McMahon’s official cause of death has been revealed days after the Nip/Tuck star's family confirmed his passing July 2 ...

A blood drive in honor of Erie resident and cancer survivor Rachel Clark is set to take place at Humes Chrysler Jeep Dodge and Ram in Waterford on July 24th. The event aims to address the urgent ...

After sharing her breast cancer diagnosis in 2024, Olivia Munn shared that her mother Kim Munn went through her own battle ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

Regular physical activity lowers cancer risk, aids recovery and improves survival. In this expert-led interview, we explore ...

The cancer often silent in its early stages, is now increasingly affecting women under 50, including those in their early 30s ...

Women seeking gynecologic care in Canada often face barriers to access, such as long wait times and dismissive attitudes.

For close to three decades, the Foundation for Heritage Preservation and Legacy Creation has been dedicated to preserving ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab)-based perioperative regimen has been approved by the European Commission (EC) to treat resectable muscle-invasive bladder cancer (MIBC).

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...